Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Abbott Laboratories (NY: ABT)
92.23 USD  +0.59 (+0.64%)
Official Closing Price  /  Updated: 7:32 PM EDT, Jul 2, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 3,845,600
Open 92.50
Bid (Size) 91.85 (3)
Ask (Size) 92.50 (1)
Prev. Close 91.64
Today's Range 91.93 - 93.06
52wk Range 61.61 - 100.00
Shares Outstanding 1,753,187,766
Dividend Yield 1.21%
Performance
YTD
+6.07%
+6.07%
1 Month
-0.42%
-0.42%
3 Month
+16.10%
+16.10%
6 Month
+6.07%
+6.07%
1 Year
+7.70%
+7.70%
Top News
More News
Abbott and Tandem Diabetes Care Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems
- Companies partner to integrate Abbott's FreeStyle Libre continuous glucose monitoring technology with Tandem's insulin delivery products to provide options to simplify and tailor diabetes management Read More
from PR Newswire
Pomerantz Law Firm Announces the Filing of a Class Action against Co-Diagnostics, Inc. and Certain Officers - CODX
Pomerantz LLP announces that a class action lawsuit has been filed against Co-Diagnostics, Inc. ("Co-Diagnostics" or the "Company")(NASDAQ: CODX) and certain of its officers. The class action, filed in... Read More
from PR Newswire
More News
Read More
New Research Finds Abbott's Optical Coherence Tomography Imaging Changed Treatment Decisions in 88% of Artery Blockages
from PR Newswire
New Late-Breaking Data Highlight Impact of Abbott's Minimally Invasive Structural Heart Therapies
from PR Newswire
Why Biomarkers for Cancer Drug Development are Becoming Increasingly Imperative
from PR Newswire
Abbott Hosts Conference Call for Second-Quarter Earnings
from PR Newswire
K-12 Education Sector Turns to Absolute for Successful Distance Learning Programs Rooted in Endpoint Resilience
from Business Wire News Releases
New Research from Absolute Underscores Vulnerability of Enterprise Devices and Critical Endpoint Controls, Reveals Opportunities to Optimize Security Investments
from Business Wire News Releases
Better Coronavirus Stock: Eli Lilly or AbbVie?
category Market News , ABT , LLY , and 2 more.
from Motley Fool
5 High-Yield Dividend Stocks to Watch
category IIPR , Market News , ABT , and 4 more.
from Motley Fool
Absolute Expands Sensitive Data and Device Protections for Remote Endpoints with Enhancements to Undeletable Defense Platform
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.